Literature DB >> 11320324

Crystallization and preliminary characterization of crystals of the C-terminal half fragment of tropomodulin.

I Krieger1, A S Kostyukova, Y Maéda.   

Abstract

Tropomodulin (40 kDa) stabilizes the actin-tropomyosin filament by capping the P end (slow-growing end). The C-terminal half (C20, 20 kDa), an independently folded domain that is believed to be responsible for the P-end capping, has been crystallized. Crystals grew in the presence of Zn(2+) as the solution pH was increased from 3 towards the pI of the protein. The crystals belong to the trigonal space group R3. They have unit-cell parameters a = b = 69.6, c = 101.3 A (mean values, with a estimated standard deviation of 0.009 A) and diffract to 1.9 A resolution when the frozen crystals were measured at 120 K on a rotating-anode X-ray source at 120 K.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320324     DOI: 10.1107/s0907444901003924

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  4 in total

1.  Folding properties of functional domains of tropomodulin.

Authors:  A S Kostyukova; E I Tiktopulo; Y Maéda
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

2.  Crystal structure of the C-terminal half of tropomodulin and structural basis of actin filament pointed-end capping.

Authors:  Inna Krieger; Alla Kostyukova; Atsuko Yamashita; Yasushi Nitanai; Yuichiro Maéda
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

3.  Mammalian tropomodulins nucleate actin polymerization via their actin monomer binding and filament pointed end-capping activities.

Authors:  Sawako Yamashiro; Kaye D Speicher; David W Speicher; Velia M Fowler
Journal:  J Biol Chem       Date:  2010-07-21       Impact factor: 5.157

4.  Role of tropomodulin's leucine rich repeat domain in the formation of neurite-like processes.

Authors:  Laurent Guillaud; Kevin T Gray; Natalia Moroz; Caroline Pantazis; Edward Pate; Alla S Kostyukova
Journal:  Biochemistry       Date:  2014-04-18       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.